Revatio 0.8 mg/ml solution for injection
APHP180603
Phase 3 small_molecule active
Quick answer
Revatio 0.8 mg/ml solution for injection for Hypoxic ischemic encephalopathy is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Hypoxic ischemic encephalopathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active